• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.共识声明:第16届加拿大西部胃肠道癌年度共识会议;萨斯喀彻温省萨斯卡通;2014年9月5日至6日。
Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.
2
Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015.第17届加拿大西部胃肠道癌年度共识会议报告;艾伯塔省埃德蒙顿;2015年9月11 - 12日
Curr Oncol. 2016 Dec;23(6):425-434. doi: 10.3747/co.23.3384. Epub 2016 Dec 21.
3
Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.第19届加拿大西部胃肠癌共识会议报告;马尼托巴省温尼伯;2017年9月29日至30日。
Curr Oncol. 2018 Aug;25(4):275-284. doi: 10.3747/co.25.4109. Epub 2018 Aug 14.
4
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.第 20 届加拿大西部胃肠癌症共识会议报告;萨斯卡通,萨斯喀彻温省;2018 年 9 月 28 日至 29 日。
Curr Oncol. 2019 Dec;26(6):e773-e784. doi: 10.3747/co.26.5517. Epub 2019 Dec 1.
5
Report from the 21st Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; 20-21 September 2019.第 21 届加拿大西部胃肠道癌症共识会议报告;艾伯塔省卡尔加里;2019 年 9 月 20-21 日。
Curr Oncol. 2021 Sep 21;28(5):3629-3648. doi: 10.3390/curroncol28050310.
6
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022.第 24 届加拿大西部胃肠道癌症共识会议关于结直肠癌的年度报告,2022 年 10 月 28-29 日,不列颠哥伦比亚省里士满。
Curr Oncol. 2023 Aug 29;30(9):7964-7983. doi: 10.3390/curroncol30090579.
7
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.加拿大西部胃肠道共识癌症会议报告-直肠癌新辅助放化疗的全程管理。
Curr Oncol. 2022 Feb 8;29(2):924-927. doi: 10.3390/curroncol29020078.
8
Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC.加拿大西部胃肠癌共识会议虚拟教育系列报告-从局部治疗向系统治疗的过渡和 HCC 系统治疗的最佳序贯。
Curr Oncol. 2021 Oct 29;28(6):4317-4327. doi: 10.3390/curroncol28060367.
9
Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.可切除性肝转移结直肠癌患者的全身治疗及其手术意义。来自加拿大西部胃肠道癌症共识会议的报告。
Curr Oncol. 2022 Mar 8;29(3):1796-1807. doi: 10.3390/curroncol29030147.
10
Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.第十三届加拿大西部胃肠道癌症共识会议报告;卡尔加里,艾伯塔省;2011 年 9 月 8 日至 10 日。
Curr Oncol. 2012 Dec;19(6):e468-77. doi: 10.3747/co.19.1167.

本文引用的文献

1
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗(ADORE):一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
2
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.FOLFIRI 联合西妥昔单抗与 FOLFIRI 联合贝伐珠单抗一线治疗转移性结直肠癌患者(FIRE-3):一项随机、开放标签、III 期临床试验。
Lancet Oncol. 2014 Sep;15(10):1065-75. doi: 10.1016/S1470-2045(14)70330-4. Epub 2014 Jul 31.
3
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control.文献标题:新辅助放化疗后局部进展期直肠癌随机 III 期临床试验结果,术后辅助卡培他滨加奥沙利铂(XELOX)与对照组比较 **解析**:这是一个医学文献的标题,其中包含了一些医学术语。在翻译时,需要注意保留关键词,如“Chronicle”(文献标题)、“randomised phase III trial”(随机 III 期临床试验)、“locally advanced rectal cancer”(局部进展期直肠癌)、“neoadjuvant chemoradiation”(新辅助放化疗)、“adjuvant capecitabine plus oxaliplatin”(术后辅助卡培他滨加奥沙利铂)、“XELOX”(药物名称)等。同时,还需要注意一些词汇的翻译,如“randomise”(随机化)、“postoperative”(术后的)等。
Ann Oncol. 2014 Jul;25(7):1356-1362. doi: 10.1093/annonc/mdu147. Epub 2014 Apr 8.
4
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.PEAK:一项随机、多中心的 II 期研究,评估帕尼单抗联合改良氟尿嘧啶、亚叶酸钙和奥沙利铂(mFOLFOX6)或贝伐珠单抗联合 mFOLFOX6 治疗既往未经治疗、不可切除、野生型 KRAS 外显子 2 转移性结直肠癌患者的疗效。
J Clin Oncol. 2014 Jul 20;32(21):2240-7. doi: 10.1200/JCO.2013.53.2473. Epub 2014 Mar 31.
5
Systematic review of surgical management of synchronous colorectal liver metastases.系统回顾结直肠肝转移同步外科治疗。
Br J Surg. 2014 May;101(6):605-12. doi: 10.1002/bjs.9449. Epub 2014 Mar 20.
6
Chemoembolization in colorectal liver metastases: the rebirth.结直肠癌肝转移的化疗栓塞治疗:重生。
Anticancer Res. 2014 Feb;34(2):575-84.
7
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.术前放化疗后氟尿嘧啶为基础的辅助化疗治疗直肠癌:EORTC 22921 随机研究的长期结果。
Lancet Oncol. 2014 Feb;15(2):184-90. doi: 10.1016/S1470-2045(13)70599-0. Epub 2014 Jan 17.
8
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.直肠癌:欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2013 Oct;24 Suppl 6:vi81-8. doi: 10.1093/annonc/mdt240.
9
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.帕尼单抗联合 FOLFOX4 治疗与结直肠癌的 RAS 突变。
N Engl J Med. 2013 Sep 12;369(11):1023-34. doi: 10.1056/NEJMoa1305275.
10
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer.评价短程放疗联合贝伐珠单抗、卡培他滨和奥沙利铂新辅助治疗及后续根治性手术治疗初诊 IV 期直肠癌的效果。
Ann Oncol. 2013 Jul;24(7):1762-1769. doi: 10.1093/annonc/mdt124. Epub 2013 Mar 22.

共识声明:第16届加拿大西部胃肠道癌年度共识会议;萨斯喀彻温省萨斯卡通;2014年9月5日至6日。

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.

作者信息

Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan K T, Wong R

机构信息

Saskatchewan: Medical Oncology (Ahmed, Sami) and Radiation Oncology (Le), Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon; Pathology (Jones), University of Saskatchewan, Regina; Surgery (Luo), Diagnostic Radiology (Rashidi), and Interventional Radiology (Tan), University of Saskatchewan, Saskatoon.

Alberta: Department of Surgery (Bathe, Buie), University of Calgary, Calgary; Radiation Oncology (Doll) and Medical Oncology (Dowden), Tom Baker Cancer Centre, University of Calgary, Calgary; Medical Oncology (Koski, Mulder), Cross Cancer Centre, University of Alberta, Edmonton.

出版信息

Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.

DOI:10.3747/co.22.2362
PMID:25908916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399619/
Abstract

The 16th annual Western Canadian Gastrointestinal Cancer Consensus Conference was held in Saskatoon, Saskatchewan, September 4-5, 2014. The Consensus Conference is an interactive, multidisciplinary event attended by health care professionals from across western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) involved in the care of gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals participated in presentation and discussion sessions for the purposes of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer.

摘要

第16届加拿大西部胃肠道癌共识会议于2014年9月4日至5日在萨斯喀彻温省萨斯卡通市举行。该共识会议是一个互动性的多学科活动,来自加拿大西部(不列颠哥伦比亚省、艾伯塔省、萨斯喀彻温省和马尼托巴省)参与胃肠道癌护理的医疗保健专业人员参加了会议。外科、医学和放射肿瘤学家;病理学家;放射科医生;以及专职医疗保健专业人员参加了演讲和讨论会议,以制定此处提出的建议。本共识声明涉及结直肠癌管理中的当前问题。